Amitiza purchasers move for judgment against Takeda in US antitrust case
( May 12, 2026, 20:57 GMT | Official Statement) -- MLex Summary: Purchasers of Amitiza asked a US federal judge to enter a judgment against Takeda Pharmaceuticals in a case accusing the company of illegally delaying generic competition to its brand name drug. They argue that a reasonable jury cannot find in favor of Takeda on the issues of purchase in each class jurisdiction and class-wide injury.See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.